The multikinase inhibitor sorafenib potentiates TRAIL lethality in human leukemia cells in association with Mcl-1 and cFLIPL down-regulation

Roberto R. Rosato, Jorge A. Almenara, Stefanie Coe, Steven Grant

Research output: Contribution to journal › Article › peer-review

112 Scopus citations

Fingerprint

Dive into the research topics of 'The multikinase inhibitor sorafenib potentiates TRAIL lethality in human leukemia cells in association with Mcl-1 and cFLIPL down-regulation'. Together they form a unique fingerprint.

Medicine & Life Sciences